JP2023549017A5 - - Google Patents
Info
- Publication number
- JP2023549017A5 JP2023549017A5 JP2023518836A JP2023518836A JP2023549017A5 JP 2023549017 A5 JP2023549017 A5 JP 2023549017A5 JP 2023518836 A JP2023518836 A JP 2023518836A JP 2023518836 A JP2023518836 A JP 2023518836A JP 2023549017 A5 JP2023549017 A5 JP 2023549017A5
- Authority
- JP
- Japan
- Prior art keywords
- coronavirus
- protein
- antigens
- vaccine composition
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063112495P | 2020-11-11 | 2020-11-11 | |
| US63/112,495 | 2020-11-11 | ||
| PCT/US2021/058856 WO2022103891A1 (en) | 2020-11-11 | 2021-11-10 | Multivalent carriers and related vaccine compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549017A JP2023549017A (ja) | 2023-11-22 |
| JP2023549017A5 true JP2023549017A5 (enExample) | 2024-11-14 |
Family
ID=81602587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518836A Pending JP2023549017A (ja) | 2020-11-11 | 2021-11-10 | 多価担体および関連するワクチン組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12440553B2 (enExample) |
| EP (1) | EP4243867A4 (enExample) |
| JP (1) | JP2023549017A (enExample) |
| KR (1) | KR20230107304A (enExample) |
| CN (1) | CN117098553A (enExample) |
| AU (1) | AU2021378792A1 (enExample) |
| CA (1) | CA3193843A1 (enExample) |
| IL (1) | IL302176A (enExample) |
| WO (1) | WO2022103891A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11740240B2 (en) * | 2020-07-20 | 2023-08-29 | Bio-Rad Laboratories, Inc. | Immunoassay for SARS-CoV-2 neutralizing antibodies and materials therefor |
| WO2024006532A2 (en) * | 2022-06-30 | 2024-01-04 | La Jolla Institute For Immunology | Kari nanoparticle |
| CN117582492A (zh) * | 2022-08-12 | 2024-02-23 | 上海市公共卫生临床中心 | 重组多价疫苗 |
| JP2025529906A (ja) * | 2022-08-22 | 2025-09-09 | ザ ヘンリー エム ジャクソン ファンデイション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド | コロナウイルスに対するワクチン |
| CN115894716B (zh) * | 2022-11-23 | 2024-02-09 | 华中农业大学 | 一种重组融合蛋白纳米颗粒及其制备方法 |
| CN117362447B (zh) * | 2023-08-25 | 2024-04-09 | 广东省农业科学院农业生物基因研究中心 | 一种基于蛋白质偶联聚合体的生物发光酶联免疫分析方法 |
| WO2025255622A1 (en) * | 2024-06-13 | 2025-12-18 | University Of Technology Sydney | Method of vaccine prototyping |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7285289B2 (en) * | 2002-04-12 | 2007-10-23 | Nagy Jon O | Nanoparticle vaccines |
| EP1778283A2 (en) * | 2004-06-30 | 2007-05-02 | ID Biomedical Corporation of Quebec | Vaccine compositions for treating coronavirus infection |
| BRPI0611336A2 (pt) | 2005-06-01 | 2010-08-31 | Dow Global Technologies Inc | método para produzir uma partìcula multivalente semelhante a vìrus, partìcula multivalente semelhante a vìrus, método de aumentar a solubilidade de uma partìcula multivalente semelhante a vìrus e vacina |
| RU2628690C2 (ru) * | 2015-11-06 | 2017-08-21 | Общество С Ограниченной Ответственностью 'Фарминтерпрайсез' | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний |
| US12194089B2 (en) * | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
-
2021
- 2021-11-10 US US17/523,813 patent/US12440553B2/en active Active
- 2021-11-10 EP EP21892767.1A patent/EP4243867A4/en active Pending
- 2021-11-10 IL IL302176A patent/IL302176A/en unknown
- 2021-11-10 CA CA3193843A patent/CA3193843A1/en active Pending
- 2021-11-10 AU AU2021378792A patent/AU2021378792A1/en active Pending
- 2021-11-10 JP JP2023518836A patent/JP2023549017A/ja active Pending
- 2021-11-10 WO PCT/US2021/058856 patent/WO2022103891A1/en not_active Ceased
- 2021-11-10 CN CN202180075832.8A patent/CN117098553A/zh active Pending
- 2021-11-10 KR KR1020237019545A patent/KR20230107304A/ko active Pending
-
2025
- 2025-08-12 US US19/298,144 patent/US20260077034A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023549017A5 (enExample) | ||
| JP2022543038A5 (enExample) | ||
| US20240002449A1 (en) | Respiratory syncytial virus (rsv) vaccine | |
| Quach et al. | Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus | |
| EP0912743B1 (fr) | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs | |
| JP2014522842A5 (enExample) | ||
| JP2023532290A5 (enExample) | ||
| RU2011122418A (ru) | Иммуностимулирующие олигонуклеотиды | |
| FR2751223A1 (fr) | Formule de vaccin polynucleotidique felin | |
| Kabiri et al. | Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles | |
| CA3193843A1 (en) | Multivalent carriers and related vaccine compositions | |
| WO2021188906A1 (en) | Novel mrna-based covid-19 multi-valent vaccine and methods of scaled production of the same | |
| US20210187096A1 (en) | Universal vaccine for viral diseases | |
| CN116234587A (zh) | 用于诱导免疫应答的免疫原性构建体、组合物和方法 | |
| US20140086952A1 (en) | Vaccine Adjuvants from Self-Assembling Peptides | |
| CN116782927A (zh) | 用于提高对抗冠状病毒的免疫力的方法及组合物 | |
| CN118765203A (zh) | 一种新型阳离子佐剂组合物 | |
| US20100166808A1 (en) | Method of Facilitating Intracellular Uptake or Transcellular Transport of Cargo Using Nanocarriers Containing Optimal Surface Densities of Integrin-Specific Ligands | |
| Singh et al. | Applications of nanotechnology in vaccine delivery | |
| JP2024518548A5 (enExample) | ||
| JP2005082581A (ja) | 分泌型ＩｇＡ抗体誘導剤 | |
| KR102731640B1 (ko) | 리포펩타이드와 폴리(i:c) 아쥬반트를 포함하는 재조합 코로나-19 백신 조성물 | |
| JP2022513913A5 (enExample) | ||
| Misra et al. | Nano-Adjuvants | |
| JPWO2022230485A5 (enExample) |